You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of CRESEMBA®...
Funding will support measles vaccination campaigns in Latin America Washington, D.C. March 5, 2015 – The United Nations Foundation’s Shot@Life Campaign, which helps expand access to...
Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb. 20, 2015 /PRNewswire/ -- Astellas Pharma US,...
NORTHBROOK, Ill., Feb. 19, 2015 /PRNewswire/ -- Astellas announces organizational and personnel changes in the Americas, highlighting the Company's focus on international markets, while also...
NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its...
Follow U.S. news
